Bill

Founder & CEO @Warburg Therapeutics

Oxford, GB

Warburg Therapeutics develops precision cancer therapies by combining computational biology, multi-omics, and AI. Our approach focuses on tumour-agnostic treatments designed to address unmet medical needs in hard-to-treat cancers.I oversee our scientific strategy, lead in silico discovery programmes, and build collaborations with academic and industry partners. My work at WarburgTx is driven by a deep commitment to transforming rigorous science into real-world solutions for patients, reflecting my belief that data-driven discovery and translational oncology can reshape the future of cancer care. For more details please visit:

University of Oxford

Master’s Degree, Radiation Biology & Oncology

University of Oxford

Doctor of Philosophy - DPhil, Bioinformatics and Computational Biology

University of Cambridge

Biotechnology Commercialisation

Saïd Business School, University of Oxford

Accounting and Finance

University of Toronto

Bachelor's Degree, Molecular Biology